JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 45:1064-1071, doi:10.1016/j.jacc.2004.12.069
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grayburn, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grayburn, P. A.

CLINICAL RESEARCH: ECHOCARDIOGRAPHY AND HEART FAILURE

Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure

The Beta-blocker Evaluation of Survival Trial (BEST)

Paul A. Grayburn, MD*,*, Christopher P. Appleton, MD{dagger}, Anthony N. DeMaria, MD{ddagger}, Barry Greenberg, MD{ddagger}, Brian Lowes, MD§, Jae Oh, MD||, Jonathan F. Plehn, MD, Peter Rahko, MD#, Martin St. John Sutton, MD**, Eric J. Eichhorn, MD* the BEST Trial Echocardiographic Substudy Investigators

* Echocardiographic Core Laboratory, Baylor University Medical Center, Dallas, Texas
{dagger} Mayo Clinic Scottsdale, Scottsdale, Arizona
{ddagger} University of California, San Diego, San Diego, California
§ University of Colorado, Denver, Colorado
|| Mayo Clinic Rochester, Rochester, Minnesota
National Heart, Lung, and Blood Institute, Washington, DC
# University of Wisconsin, Madison, Wisconsin
** University of Pennsylvania, Philadelphia, Pennsylvania

Manuscript received October 11, 2004; revised manuscript received December 3, 2004, accepted December 20, 2004.

* Reprint requests and correspondence: Dr. Paul A. Grayburn, Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, Texas 75226 (Email: paulgr{at}baylorhealth.edu).

OBJECTIVES: The aim of this study was to determine echocardiographic predictors of outcome in patients with advanced heart failure (HF) due to severe left ventricular (LV) systolic dysfunction in the Beta-blocker Evaluation of Survival Trial (BEST).

BACKGROUND: Previous studies indicate that echocardiographic measurements of LV size and function, mitral deceleration time, and mitral regurgitation (MR) predict adverse outcomes in HF. However, complete quantitative echocardiograms evaluating all of these parameters have not been reported in a prospective randomized clinical trial in the era of modern HF therapy.

METHODS: Complete echocardiograms were performed in 336 patients at 26 sites and analyzed by a core laboratory. A Cox proportional-hazards regression model was used to determine which echocardiographic variables predicted the primary end point of death or the secondary end point of death, HF hospitalization, or transplant. Significant variables were then entered into a multivariable model adjusted for clinical and demographic covariates.

RESULTS: On multivariable analysis adjusted for clinical covariates, only LV end-diastolic volume index predicted death (events = 75), with a cut point of 120 ml/m2. Three echocardiographic variables predicted the combined end point of death (events = 75), HF hospitalization (events = 97), and transplant (events = 9): LV end-diastolic volume index, mitral deceleration time, and the vena contracta width of MR. Optimal cut points for these variables were 120 ml/m2, 150 ms, and 0.4 cm, respectively.

CONCLUSIONS: Echocardiographic predictors of outcome in advanced HF include LV end-diastolic volume index, mitral deceleration time, and vena contracta width. These variables indicate that LV remodeling, increased LV stiffness, and MR are independent predictors of outcome in patients with advanced HF.

Abbreviations and Acronyms
  BEST = Beta-blocker Evaluation of Survival Trial
  CHF = congestive heart failure
  EROA = effective regurgitant orifice area
  HF = heart failure
  LV = left ventricle/ventricular
  LVEF = left ventricular ejection fraction
  MR = mitral regurgitation
  NYHA = New York Heart Association
  SAVE = Survival And Ventricular Enlargement trial
  SOLVD = Studies Of Left Ventricular Dysfunction trial
  Val-HeFT = Valsartan in Heart Failure Trial




This article has been cited by other articles:


Home page
HeartHome page
B G. Svealv, E L Olofsson, and B Andersson
Ventricular long-axis function is of major importance for long-term survival in patients with heart failure
Heart, March 1, 2008; 94(3): 284 - 289.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
M. Enriquez-Sarano, V. T. Nkomo, and H. Michelena
Principles and Practice of Echocardiography in Cardiac Surgery
Card. Surg. Adult, January 1, 2008; 3(2008): 315 - 348.
[Full Text]


Home page
Eur J EchocardiogrHome page
A. M. Dart, J. E. Otterstad, B.-A. Kirwan, J. D. Parker, S. de Brouwer, P. A. Poole-Wilson, and J. Lubsen
Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina: The ACTION study
Eur J Echocardiogr, August 1, 2007; 8(4): 275 - 283.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. N. Kirkpatrick, M. A. Vannan, J. Narula, and R. M. Lang
Echocardiography in Heart Failure: Applications, Utility, and New Horizons
J. Am. Coll. Cardiol., July 31, 2007; 50(5): 381 - 396.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
J.K. Oh
Echocardiography in heart failure: Beyond diagnosis
Eur J Echocardiogr, January 1, 2007; 8(1): 4 - 14.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. G. Neilan, D. S. Jassal, T. M. Perez-Sanz, M. J. Raher, A. D. Pradhan, E. S. Buys, F. Ichinose, D. B. Bayne, E. F. Halpern, A. E. Weyman, et al.
Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury
Eur. Heart J., August 1, 2006; 27(15): 1868 - 1875.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. A. Chen, M. J. Wood, D. G. Krauser, A. L. Baggish, R. Tung, S. Anwaruddin, M. H. Picard, and J. L. Januzzi
NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy
Eur. Heart J., April 1, 2006; 27(7): 839 - 845.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 184 - 202.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.